Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps: Association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials. Issue 9 (31st January 2022) - Bachert, Claus; Corren, Jonathan; Lee, Stella E.; Zhang, Haixin; Harel, Sivan; Cunoosamy, Danen; Khan, Asif H.; Jacob‐Nara, Juby A.; Siddiqui, Shahid; Nash, Scott; Rowe, Paul J.; Deniz, Yamo